-+ 0.00%
-+ 0.00%
-+ 0.00%

Olema Pharmaceuticals Q2 EPS $(0.61) Misses $(0.55) Estimate

Benzinga·08/10/2026 20:29:00
Listen to the news
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.55) by 10.91 percent. This is a 19.61 percent decrease over losses of $(0.51) per share from the same period last year.